Ebola vaccine, ERVEBO, now approved for use in children 12 months of age and older
by Press Release from Outbreak News Today on (#6DMQV)
NewsDesk@bactiman63 Merck announced Thursday that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for ERVEBO, which is now indicated for the prevention of disease caused byZaire ebolavirusin individuals 12 months of age and older. The vaccine waspreviously approvedfor use in individuals 18 years of age and older. ERVEBO does not protect [...]
The post Ebola vaccine, ERVEBO, now approved for use in children 12 months of age and older appeared first on Outbreak News Today.